THE LEADING RESEARCH REPORTS DISTRIBUTION
NETWORK

icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research  icrowd research

Cancer Vaccines Market to grow at 17.7% CAGR during 2018-2023 examined in new market research report




May 22, 2019



A vaccine is a biological preparation that strengthens the immune system and provides acquired immunity against a specific pathogen. According to the World Health Organization (WHO), cancer vaccines are popularly for treating various types of cancer such as breast cancer, lung cancer, cervical cancer, and others. The key factors that drive the market growth include the rise in the prevalence of human papillomavirus (HPV) infections leading to cancers, increase in the administration of prophylactic cancer vaccines, the surge in investments in the development of cancer vaccines by manufacturers & governmental funding, and launch & approval of novel cancer vaccines in the market. The global cancer vaccines market was valued at $4,073 million in 2016 and is expected to reach $12,814 million by 2023, registering a CAGR of 17.7% from 2017 to 2023.

 

The global cancer vaccines market is segmented based on technology, indication, type end use, and region. Based on technology, it is categorized into dendritic cells (DC) cancer vaccines, recombinant cancer vaccines, antigen/adjuvant cancer vaccines, whole cell cancer vaccines, and viral vector & DNA cancer vaccines. Based on indication, it is bifurcated into cervical cancer, prostate cancer, and others. On the basis of end use, it is classified into pediatric vaccines and adult vaccines. Based on type, the market is divided into therapeutic cancer vaccines and preventive cancer vaccines.

 

Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in 2016 and is expected to maintain its dominance throughout the forecast period. This is attributed to the increase in the prevalence of cervical cancers, the rise in government focus on immunization programs, the emergence of new vaccines, and growth in technological advancements in vaccine administration. However, Asia-Pacific is expected to witness maximum growth potential, due to the improvement in healthcare facilities, high disposable income, and rapid development of economic conditions.

 

KEY BENEFITS

The study provides an in-depth analysis of the global cancer vaccines market with current trends and future estimations to elucidate the imminent investment pockets.

Comprehensive analysis of factors that drive and restrict market growth is provided in the report.

Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.

Extensive analysis of the key segments of the industry to understand the type of products and technologies used globally.

Key market players and their strategies are provided to understand the competitive outlook of the market.

 

KEY MARKET SEGMENTS

BY TECHNOLOGY

Dendritic Cells (DC) Cancer Vaccines
Recombinant Cancer Vaccines
Antigen/Adjuvant Cancer Vaccines
Whole Cell Cancer Vaccines
Viral Vector & DNA Cancer Vaccines

 

BY TYPE

Preventive Cancer Vaccines
Therapeutic Cancer Vaccines

 

BY INDICATION

Cervical Cancer
Prostate Cancer
Others

 

BY END-USE

Pediatrics
Adults

 

BY REGION

North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
Argentina
Turkey
South Africa
Rest of LAMEA

 

KEY PLAYERS PROFILED

AstraZeneca PLC. (Medimmune, LLC.)
GlaxoSmithKline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Aduro BioTech Inc.
Astellas Pharma Inc.
CSL Limited
Pfizer Inc.
Sanpower Group
Serum Institute of India Pvt. Ltd.

 

The other players in the value chain include (profiles not included in the report)

Gritstone Oncology
PaxVax Corporation.
Bavarian Nordic
Bharat Biotech.
VBI Vaccines Inc.
Novavax, Inc.
Dynavax Technologies Corporation
Immunomic Therapeutics, Inc.
Gamma Vaccines Pty Limited
Sinovac Biotech Ltd.
Prokarium
ImmunoBiology Ltd.
Galena Biopharma

 

Continue…

Note: The study base year and forecast period can be customized as per the request. Also, the table of contents is the defined scope of a published report. As per client requirement, cross-sectional analysis across all industries or specific geography or ‘country-based’ analysis can be provided as a part of customization

 

Get more information, Ask for free sample copy: https://www.reportocean.com/industry-verticals/sample-request?report_id=27083

 

About us:

We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports. We will help you in finding the upcoming trends that will entitle you as a leader in the industry. We are here to work with you on your objective which will create an immense opportunity for your organization.

Contact us:
Company Name: Report Ocean
Address: Classic Tower, Rajnagar Extension, Ghaziabad, 201017 – India
Contact: +1 888 212 3539 (US) +91-9997112116 (Outside US)
Contact Person: Sandeep Singh
URL: www.reportocean.com
Email: sales@reportocean.com

Tags: , , , , , , , , , , , , , , , , , , , ,

See Campaign: https://www.reportocean.com/industry-verticals/sample-request?report_id=27083
Contact Information:
+91-9997112116

Tags:
, Research Newswire, English